ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $87,000 | -62.5% | 30,229 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $232,000 | -42.3% | 30,229 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $402,000 | -14.6% | 30,229 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $471,000 | -20.7% | 30,229 | 0.0% | 0.01% | -14.3% |
| Q3 2018 | $594,000 | -35.6% | 30,229 | -5.9% | 0.01% | -36.4% |
| Q2 2018 | $923,000 | +4.5% | 32,129 | -13.9% | 0.01% | 0.0% |
| Q1 2018 | $883,000 | +10.2% | 37,332 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $801,000 | -8.8% | 37,332 | +0.6% | 0.01% | -8.3% |
| Q3 2017 | $878,000 | +66.6% | 37,120 | +38.9% | 0.01% | +71.4% |
| Q2 2017 | $527,000 | +147.4% | 26,720 | +164.2% | 0.01% | +133.3% |
| Q1 2017 | $213,000 | +11.5% | 10,113 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $191,000 | -16.2% | 10,113 | -7.2% | 0.00% | 0.0% |
| Q3 2016 | $228,000 | -19.4% | 10,893 | -1.8% | 0.00% | -40.0% |
| Q2 2016 | $283,000 | -14.2% | 11,092 | +44.1% | 0.01% | -28.6% |
| Q4 2015 | $330,000 | – | 7,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,045,400 | $21,953,000 | 12.28% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,568,306 | $116,934,000 | 2.16% |
| GREAT POINT PARTNERS LLC | 432,500 | $9,083,000 | 1.80% |
| Consonance Capital Management LP | 619,419 | $13,008,000 | 1.36% |
| RA Capital Management | 489,828 | $10,286,000 | 1.26% |
| Ghost Tree Capital, LLC | 300,000 | $6,300,000 | 1.17% |
| DLD Asset Management, LP | 281,900 | $5,920,000 | 0.95% |
| DLD Asset Management, LP | 281,900 | $5,914,000 | 0.95% |
| Worth Venture Partners, LLC | 36,650 | $770,000 | 0.68% |
| Malaga Cove Capital, LLC | 51,013 | $939,000 | 0.57% |